跳至主要内容
临床试验/EUCTR2009-009871-36-DE
EUCTR2009-009871-36-DE进行中(未招募)不适用

Effect and Safety of preventive Treatment with ACE-Inhibitor and Beta-Blocker on the onset of Left Ventricular Dysfunction in Duchenne Muscular Dystrophy - DMD-Kardio

Friedrich- Alexander- Universität Erlangen Nürnberg0 个研究点开始时间: 2009年8月6日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Male patients with DMD (confirmed by genetic analysis or muscle biopsy) • aged 10 – 14 years • Normal left ventricular function (fraction shortening = 30%) • Normal renal function (GFR > 30 ml/min/1,73 m2) • Informed Consent of both parents, assent of patient
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 55
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Dilated left ventricle (size > 97. Percentile) or Left Ventricular Dysfunction (fraction shortening <30%) • contraindications for ACE-Inhibitors/Beta-Blocker • previous therapy with ACE-Inhibitors, AT II Antagonists, Beta-Blockers • Other medical reasons which render participation not reasonable for the patient

研究者

相似试验

Study within children with Duchenne Muscular... | 临床试验